ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,633.91
1.02%
US Tech 100
20,118.40
0.00%
Dow Jones
39,721.36
1.09%
Brent Oil
85.125
0.09%
Bitcoin
58,103.76
0.60%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
06/01/20218:46AMDow Jones NewsImmutep in Collaboration, Supply Agreement With Merck KGaANYSE:GSKGSK plc
06/01/20218:14AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/27/20214:12PMEdgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:GSKGSK plc
05/27/20217:08AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/27/20212:28AMDow Jones NewsSanofi, GSK Covid-19 Vaccine Begins Major Trials, Aiming for Approval by Year EndNYSE:GSKGSK plc
05/27/20211:41AMDow Jones NewsGlaxoSmithKline Isn't Being Pressured Into Sale by Elliott -The TimesNYSE:GSKGSK plc
05/26/20217:17PMDow Jones NewsCovid-19 Treatment From Vir, GlaxoSmithKline Is Approved -- UpdateNYSE:GSKGSK plc
05/26/20216:57PMGlobeNewswire Inc.GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives Emergency Use Authorization from the US FDA for Treatment o...NYSE:GSKGSK plc
05/26/20216:37PMDow Jones NewsCovid-19 Treatment From Vir, GlaxoSmithKline Is ApprovedNYSE:GSKGSK plc
05/24/20216:48AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/21/20218:40AMDow Jones NewsGlaxoSmithKline's Covid-19 Therapy Receives Favorable Opinion From EMANYSE:GSKGSK plc
05/21/20218:29AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/20/202110:23AMDow Jones NewsInnoviva Buys Back GlaxoSmithKline's Stake for $392 MillionNYSE:GSKGSK plc
05/18/20219:38AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/18/20219:00AMPR Newswire (US)Advil Teams Up with Actor and Comedian Anthony Anderson to Inspire People Everywhere to Reclaim Life's Possibilities After Va...NYSE:GSKGSK plc
05/18/20216:30AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/17/20219:32AMDow Jones NewsGlaxoSmithKline Gets Support From Leading Shareholders Over Elliott Management Shake-Up Bid -The TimesNYSE:GSKGSK plc
05/17/20218:31AMDow Jones NewsSanofi-GSK Covid-19 Vaccine Set for Large-Scale Trials After Positive ResultsNYSE:GSKGSK plc
05/17/20212:20AMDow Jones NewsSanofi-GSK Covid-19 Vaccine Trial Passes Phase 2; Phase 3 to Start SoonNYSE:GSKGSK plc
05/14/20218:36AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NYSE:GSKGSK plc
05/11/20218:58AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/11/20217:18AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/07/20215:53AMGlobeNewswire Inc.GSK and Vir Biotechnology Announce the Start of the EMA Rolling Review of VIR-7831 (sotrovimab) for the Early Treatment of C...NYSE:GSKGSK plc
05/04/20211:26PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/03/20219:37AMPR Newswire (US)Voltaren Arthritis Pain Gel Empowers Early Morning Risers Living with OsteoarthritisNYSE:GSKGSK plc
04/28/20211:31PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
04/28/20211:20PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
04/28/202110:43AMDow Jones NewsGlaxoSmithKline 1Q Missed Expectations on Pharmaceuticals, Vaccines -- Earnings ReviewNYSE:GSKGSK plc
04/28/20217:57AMDow Jones NewsGlaxoSmithKline 1Q Profit, Sales Declined; Backs 2021 OutlookNYSE:GSKGSK plc
04/26/202111:59AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Your Recent History

USOTC
AABB
Asia Broadband (PK)
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
MAXN
Maxeon Solar Technologies
NASDAQ
FCEL
FuelCell Energy
USOTC
RONN
Ronn Motor (PK)
USOTC
RDGL
Vivos (QB)
USOTC
RXMD
Progressive Care (QB)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
IFUS
Impact Fusion (PK)
USOTC
AXXA
Exxe (PK)
USOTC
VXIT
Virexit Technologies (PK)
AMEX
SPY
SPDR S&P 500
USOTC
RNVA
Rennova Health (PK)
NASDAQ
AMRN
Amarin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved